27th Feb 2012 07:00
27 February 2012 Source BioScience plc ("Source BioScience" or the "Company") Appointment of Financial Advisor, Sponsor and Broker
Source BioScience , the international diagnostics and genetic analysis business, is pleased to announce the appointment, with immediate effect, of Nplus1 Brewin LLP ("N+1 Brewin") as the Company's Financial Advisor, Sponsor and Broker.
For further information, please contact:
Source BioScience plcDr Nick Ash, CEOTel: +44 (0)115 973 9010
Email: [email protected]
www.sourcebioscience.com
N+1 Brewin (Financial Advisor, Sponsor and Broker)
Aubrey Powell/Luke Boyce
Tel: + 44 (0) 203 201 3710
College Hill (PR Agency to Source BioScience)
Melanie Toyne-Sewell/Jayne Crook
Tel: +44 (0)207 457 2020
Mob: +44 (0)7890 022814 / +44 (0)7979 462044
Email: [email protected]
Notes to Editors
About Source BioScience:
Source BioScience plc is an international diagnostics and genetic analysis business serving the healthcare and research markets. The LifeSciences division provides core laboratory research support from conceptualisation to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. The Company is a trusted provider of a complete range of sophisticated microarray, next generation and conventional sequencing services. GLP, GCP and CPA accreditations make the sequencing offerings also very attractive for applications in regulatory studies or clinical settings. Its Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. The Group has its headquarters in Nottingham, UK. Further information about Source BioScience can be found at www.sourcebioscience.com
XLONRelated Shares:
SBS.L